Author

Bao‐Hong Yuan

Observed name: Bao-Hong Yuan

Institution: Yan'an Hospital Affiliated To Kunming Medical University

Observed institutions: Kunming Medical University, Yan'an Hospital Affiliated To Kunming Medical University

ORCID: 0000-0001-9171-3572

Observed ORCID: 0000-0001-9171-3572

OpenAlex ID: A5029134367

Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges

2017 · Jin-Fang Jiang, Yong-Cong Lao, et al. · Oncotarget · 87

A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

2024 · Huai Zhang, Giovanni Targher, et al. · Hepatology International · 40

Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis

2022 · Bao‐Hong Yuan, Ru‐Hong Li, et al. · Journal of Gastroenterology and Hepatology · 31

Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma

2015 · Bao-Hong Yuan, Wei-Ping Yuan, et al. · Tumor Biology · 23

Repeat hepatic resection versus percutaneous ablation for the treatment of recurrent hepatocellular carcinoma: meta-analysis

2022 · Bao-Hong Yuan, Yan-Kun Zhu, et al. · BJS Open · 21

Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy

2017 · Han-Yue Mo, Ying-Yang Liao, et al. · PLoS ONE · 16

Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review

2017 · Bao-Hong Yuan, Ru-Hong Li, et al. · Oncotarget · 11

Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching

2017 · Bao-Hong Yuan, Ru-Hong Li, et al. · Oncotarget · 10

lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy

2024 · Zhu-Jian Deng, Hao-Tian Liu, et al. · Clinical & Translational Oncology · 3

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?

2019 · Bao‐Hong Yuan, Yan‐Kun Zhu, et al. · Alimentary Pharmacology & Therapeutics · 2

Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward

2021 · Bao-Hong Yuan, Yan-Kun Zhu, et al. · Clinical Gastroenterology and Hepatology

Perioperative antiviral therapy for patients with hepatitis B virus related hepatocellular carcinoma with low HBV DNA levels

2017 · Bao‐Hong Yuan, Li Ruhong, et al. · Zhonghua gan-dan waike zazhi

WITHDRAWN: Transarterial embolization for hepatocellular adenomas: a literature review

2017 · Bao-Hong Yuan, Ru-Hong Li, et al. · Oncotarget

Works count: 13

Citation count: 244

H-index: 8

I10-index: 8